Actively Recruiting
Insights on Dissemination of Lung Cancer
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2026-03-17
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
CONDITIONS
Official Title
Insights on Dissemination of Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 218 years
- Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma)
- Patients deemed fit for surgical or multimodal treatment
- Informed consent obtained
- Treatment includes surgery, either alone or as part of multimodal therapy
You will not qualify if you...
- Histology other than adenocarcinoma or squamous cell carcinoma
- Other cancers concurrent with or treated by systemic therapies in the previous three years
- Age under 18 years
- No need for surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Università di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
P
Pietro Bertoglio
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here